© 2021 BioMarin. All rights reserved.

BioMarin to Attend Upcoming Investor Conference
- Cowen and Company 38th Annual Health Care Conference on March 13 in Boston
Mar 6, 2018

SAN RAFAEL, Calif., March 6, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Cowen and Company 38th Annual Health Care Conference on March 13, 2018 at 10:40am ET in Boston.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth  

BioMarin Pharmaceutical Inc.  

BioMarin Pharmaceutical Inc.  

(415) 455-7558  

(415) 455-7451  

 

SOURCE BioMarin Pharmaceutical Inc.